To estimate the theoretically consistent welfare measure for non-marginal changes, the demand functions should be estimated.
Day et al. [19] also estimate the theoretically consistent welfare measures for non-marginal changes, the second step in the hedonic method [61].6.
The trade-offs are the marginal changes between the optimised solutions rather than the costs of production per se; they thus give an indication of the financial incentive required to change production based on the profit maximising objective assumed in MEETA.
Given the marginal changes in the ATP ratio after the mitochondrial drug treatments, it seems unlikely that ATP depletion is a main reason for inhibition by the mitochondrial antagonists of the pMV-absorption.
Looking at the coefficients, however, their perception is already worse, which might explain the marginal changes during the course of study.
However, in the literature, studies have imposed marginal changes on the format of the initial rating scale.
Continuing the analysis of the value of the estimated parameters, Table 5 includes a series of regressions (OLS) in which the independent variable is the marginal change in the probability (the values of the estimated parameters from the columns in Table 4, by community), and the dependent variable is the degree of traditionalism, measured using ERI.
The analysis indicated only marginal changes in the precipitation, albeit changes will occur during the middle of the modelled period (Fig. 3).
Outcome measures were survival of implants, complications, marginal changes in the height of the bone, and soft tissue variables (pocket probing depth and bleeding on probing).
While a better fitting model for heart rate data was achieved when eliminating patients with atrial fibrillation from the regression, this reduced model caused only marginal changes in the effect estimates for covariates at the third significant digit, with the exception of neutrophil count (OR: 1.42 (1.10–1.83) for a 5 × 10/ml increase).
This is mostly due to the inelasticity of the optimal coverage to marginal changes in the efficacy of immunisation and screening in preventing HPV-related diseases, estimated in the model as 91%and37%7%, respectively.
